CNMD240719P65000
- 0.72
- 0.000.00%
ConMed Newsroom
Analysts Conflicted on These Healthcare Names: Ionis Pharmaceuticals (IONS), Conmed (CNMD) and PTC Therapeutics (PTCT)
Conmed Analyst Ratings
Conmed's Resilience Justifies Buy Rating Amid New Market Challenges
Analysts Offer Insights on Healthcare Companies: Thermo Fisher (TMO), Conmed (CNMD) and BioMarin Pharmaceutical (BMRN)
Piper Sandler Sticks to Their Buy Rating for Conmed (CNMD)
Conmed Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: SI-Bone (SIBN), Conmed (CNMD) and Chemed (CHE)
Needham Lowers Price Target on CONMED to $107 From $129, Notes Slight Guidance Cut Due to Currency, Keeps Buy Rating
Conmed's Resilient Performance and Promising Outlook Merit a Buy Rating
Conmed Analyst Ratings
Analysts Conflicted on These Healthcare Names: Conmed (CNMD), AbbVie (ABBV) and Nurix Therapeutics (NRIX)
Piper Sandler Sticks to Their Buy Rating for Conmed (CNMD)
Analysts Offer Insights on Healthcare Companies: ATyr Pharma (LIFE), Conmed (CNMD) and Ascendis Pharma (ASND)
JPMorgan Cuts CONMED Price Target to $115 From $135, Maintains Overweight Rating
Conmed Analyst Ratings
Conmed Performance Review: Hold Rating With Cautious Growth and Margin Outlook
Analysts Offer Insights on Healthcare Companies: Conmed (CNMD), Roche Holding AG (OtherRHHVF) and Sanofi (OtherSNYNF)
Hold Rating on Conmed Amid Competitive Pressures and Growth Uncertainties
Analysts Are Bullish on These Healthcare Stocks: Conmed (CNMD), Illumina (ILMN)
Analysts Are Bullish on These Healthcare Stocks: Conmed (CNMD), Resmed (RMD)